Canada’s Intellectual Property Law Firm

Aleksandra (Sasha) Gracia

Instructions: Click the print button to generate a PDF bio with the default options. To customize the bio with additional sections, select any of the options on the right before printing.

Default Options

  • Bio
  • Qualifications
  • Related Services
  • Related Industries

More Options

Aleksandra (Sasha) Gracia

  • Smart & Biggar LLP
Barrister and Solicitor

IP lawyer with expertise in life sciences innovation and regulatory law

Aleksandra’s practice focuses on securing patent protection for pharmaceutical, biotechnology, and other inventions in life sciences. She brings deep technical expertise in biochemistry, microbiology and immunology to her work with clients in the biotechnology and pharmaceutical industries. She also works in the area of pharmaceutical regulatory law, providing strategic advice both during and after patent prosecution for pharmaceuticals and biologics.

Aleksandra received her Bachelor of Science degree in Biochemistry and Microbiology from the University of Victoria. During her graduate studies, she participated in the Vaccine & Infectious Disease Organization's (VIDO) - International Vaccine Centre (InterVac) Neonatal Immunization Group. At VIDO, with funding from the Bill & Melinda Gates Foundation, she assisted in the development of a new vaccine adjuvant platform for use in the immunization of infants in developing countries. Aleksandra completed her doctorate degree in Immunology & Vaccinology while enrolled in her second year of law school, both at the University of Saskatchewan.


  • News
  • Industry Involvement
  • In the Media


  • Associate, Intellectual Property Institute of Canada
  • Member, The Advocacy Club
  • Keeping up with technology – goods versus services,” World Trademark Review Daily, April 6, 2016
  • “Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies” (co-authors: Monika Polewicz et al.), Vaccine, June 28, 2013, Volume 31, Issue 31, pp. 3148-3155
  •  “Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations” (co-authors: Monika Polewicz et al.), Vaccine, October 13, 2011, Volume 29, Issue 44, pp. 7718-7726
  • “Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets” (co-authors: Monika Polewicz et al.), Vaccine, February 11, 2011, Volume 29, Issue 8, pp. 1595-1604